CRM1表达:在喉癌中具有高预后价值的关联
Talih Özdaş1, Sibel Özdaş2, İpek Canatar2
1Department of Otorhinolaryngology, Adana City Training and Research Hospital, Health Science University, Adana, Turkiye.
Turkish journal of medical sciences
|November 30, 2023
概括
染色体维护区域1 (CRM1) 在喉癌中升高,与晚期疾病和生存率差相关. 这一发现表明CRM1是头癌的潜在预后标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 喉癌是一种普遍存在的头恶性瘤,晚期预后不佳.
- 染色体维护区域1 (CRM1) 与各种癌症有关,但其在喉癌中的作用尚不清楚.
- 喉癌的早期症状往往不存在,使诊断和治疗复杂化.
研究的目的:
- 在喉癌组织中确定CRM1基因表达水平.
- 调查CRM1表达和临床病理学参数之间的关联.
- 评估CRM1作为喉癌患者存活率的预后因素.
主要方法:
- 分析了43个结对的喉瘤和正常组织中的CRM1蛋白和mRNA水平.
- 使用免疫组织化学染色 (IHC),西部斑点和定量实时RT-PCR (qRT-PCR).
- 与临床病理特征和患者生存数据相关的CRM1表达.
主要成果:
- 与正常组织相比,喉癌组织中CRM1表达显著上调.
- 较高的CRM1水平与晚期瘤阶段,入侵,转移和生存率低下相关 (p=0.007).
- TCGA数据证实CRM1与头癌的晚期和等级相关.
结论:
- CRM1在喉癌的发病过程中发挥着重要作用.
- CRM1表达是喉癌预后不佳的潜在指标.
- 向CRM1可能为喉癌患者提供治疗策略.
相关概念视频
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


